277 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
to the Company’s by-laws, your successor is elected and duly qualified, or until your earlier death, disability resignation or removal. If at any time … Outside of the Change in Control Period. If the Company terminates your employment without Cause (and not as a result of your death or Disability) or you
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
(and not as a result of your death or Disability) outside of the Change in Control Period (as such capitalized terms are defined in Appendix … Within the Change in Control Period. If the Company terminates your employment without Cause (and not as a result of your death or Disability) within
8-K
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
. In addition, in the event of his termination due to death or disability, Dr. Klein’s Amended Agreement provides for accelerated vesting of all
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
account will be returned to the participant (or his or her estate or designated beneficiary in the event of the participant’s death), without interest
8-K
EX-3.5
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
any increase in the authorized number of directors or any vacancies in the Board of Directors resulting from death, resignation, retirement … current term or his or her prior death, retirement, removal or resignation and (b) the newly created or eliminated directorships resulting from
8-K
EX-10.11
gan8ifxw55o4
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.10
4kkb8 np1j
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-3.6
87wjvtmn689z2d369o
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
EX-10.16
1wpe1vgkktt5eeu
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
8-K
kptifwq0ziz 6rfg
23 Aug 24
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
4:35pm
424B3
rcczmdv9w5d1
1 Aug 24
Prospectus supplement
4:10pm